The author aims to review the various strategies and avenues for fertility preservation despite gonadotoxic chemotherapy in young women. The recent increase in the survival of young patients has increased the worldwide attempts toward fertility preservation. The currently utilized methods are sperm cryopreservation and banking in male patients, and cryopreservation of embryos, unfertilized oocytes and ovarian tissue, as well as administration of gonadotropin-releasing hormone agonists (GnRH-a) before and during the gonadotoxic chemotherapy in young female patients. For those patients in whom pelvic irradiation is planned, ovariopexy is suggested. Since none of the suggested methods are ideal and none guarantees future fertility, a combination of several methods may optimize patients' chance of fertility preservation. GnRH-a co-treatment may reduce ovarian damage significantly in female patients treated with gonadotoxic chemotherapy. GnRH-a should be considered for women of reproductive age receiving gonadotoxic chemotherapy in addition to assisted reproduction and cryopreservation of embryos, oocytes and ovarian tissue.
Keywords: GnRH agonist; chemotherapy; fertility preservation; gonadotoxicity; premature ovarian failure.
How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.Oncologist. 2007 Sep;12(9):1044-54. doi: 10.1634/theoncologist.12-9-1044. Oncologist. 2007. PMID: 17914074 Review.
Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.Expert Opin Pharmacother. 2015 May;16(7):1009-20. doi: 10.1517/14656566.2015.1031654. Epub 2015 Mar 31. Expert Opin Pharmacother. 2015. PMID: 25826240 Review.
Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women.J Soc Gynecol Investig. 1999 Sep-Oct;6(5):229-39. doi: 10.1016/s1071-5576(99)00028-3. J Soc Gynecol Investig. 1999. PMID: 10554760 Review.
Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.Oncologist. 2015 Nov;20(11):1283-9. doi: 10.1634/theoncologist.2015-0223. Epub 2015 Oct 13. Oncologist. 2015. PMID: 26463871 Free PMC article.
Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers.Mol Cell Endocrinol. 2002 Feb 22;187(1-2):93-105. doi: 10.1016/s0303-7207(01)00712-2. Mol Cell Endocrinol. 2002. PMID: 11988316 Review.
Cited by 1 article
Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy.Clin Med Insights Reprod Health. 2019 Aug 21;13:1179558119870163. doi: 10.1177/1179558119870163. eCollection 2019. Clin Med Insights Reprod Health. 2019. PMID: 31488958 Free PMC article. Review.